Viewing Study NCT05542056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:25 PM
Ignite Modification Date: 2026-02-20 @ 3:44 PM
Study NCT ID: NCT05542056
Status: RECRUITING
Last Update Posted: 2025-07-01
First Post: 2022-09-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia
Sponsor: University Hospital, Basel, Switzerland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thiazide-induced Hyponatremia (TIH) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Thiazide View
None Thiazide-like diuretics View
None Hyponatremia View
None Prostaglandin E2 (PGE2) View
None Urinary PGE2 concentration View
None Plasma sodium level View
None Urinary prostaglandins View